Big pharma in legal battles for monopoly prices in India
Data(s) |
05/06/2012
|
---|---|
Resumo |
Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s future as a major global supplier of low-cost essential medicines.<br /> |
Identificador | |
Idioma(s) |
eng |
Publicador |
The Conversation Media Trust |
Relação |
http://theconversation.edu.au/big-pharma-in-legal-battles-for-monopoly-prices-in-india-4472 |
Palavras-Chave | #pharmaceutical policy #India #access to medicines |
Tipo |
Media Article |